Calix, inc (CALX)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

-14,871

-17,694

-23,769

-19,581

-17,329

-19,298

-

-26,586

-45,248

-61,443

-83,032

-81,649

-63,160

-49,998

-27,402

-25,465

-25,179

-25,132

-26,333

-19,775

-24,545

-22,717

-20,814

-24,279

-19,887

-21,089

-17,265

-17,386

-25,070

-27,008

-28,326

-26,966

-26,760

-37,315

-52,550

0

0

0

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Stock-based compensation

11,020

11,181

18,149

17,886

17,861

17,473

-

10,854

11,351

11,585

12,368

13,233

14,914

15,104

14,285

13,578

11,491

12,864

13,805

14,491

15,714

15,777

16,017

17,075

18,233

19,104

19,921

19,441

18,777

17,841

17,437

17,327

16,816

17,801

21,603

0

0

0

Depreciation and amortization

11,579

10,316

9,502

8,889

8,845

9,187

-

10,451

11,004

11,151

10,991

9,669

9,117

8,827

8,319

8,942

9,415

9,737

10,262

10,093

9,719

9,472

9,263

9,186

9,340

9,598

10,181

9,978

9,796

9,456

8,562

0

0

0

-

-

-

-

Loss on asset retirements

-2,541

-2,636

-2,639

-217

-177

-326

-

-443

-447

-444

-280

-148

-80

-80

0

-10

-19

-14

-24

-23

-55

-60

-50

-46

-9

-27

-569

0

0

0

-

-

-

-

-

-

-

-

Loss on retirement of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Amortization of intangible assets

-

-

-

-

-

-

-

-

-

-

-

1,627

2,440

3,254

5,805

9,632

13,459

17,285

18,561

18,560

18,561

18,561

18,561

18,561

18,561

18,561

18,561

18,561

18,560

18,560

17,747

17,702

18,420

19,763

18,121

0

0

0

Amortization of premium (discount) relating to available-for-sale securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-263

-382

-501

-599

-734

-907

-1,015

-1,007

-861

-574

0

0

0

-

-

-

-

-

-

-

-

-244

0

0

0

Gain on sale of product line

-

-

-

-

-

6,704

-

6,704

6,704

6,704

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-295

-295

-295

-295

0

0

0

0

-

-

-

-

-754

0

0

0

-

-

-

0

Accounts receivable, net

11,933

-20,517

-19,139

-9,350

-544

-13,858

-

22,952

15,652

-8,933

29,056

-13,028

4,278

20,388

4,185

9,072

7,134

4,804

16,411

5,406

-5,345

-5,134

-12,776

-11,640

-15,397

-26,583

-15,999

-1,446

7,562

23,373

13,011

7,966

-2,776

-8,709

-13,722

0

0

0

Inventory

-16,687

-9,998

16,089

25,372

20,165

20,639

-

-4,037

-17,567

-17,460

-13,016

-3,869

-1,189

5,411

-3,122

-3,579

51

490

915

-76

-5,178

-4,423

-4,319

2,818

6,835

4,177

6,138

-359

-5,779

-7,707

-11,308

-13,778

-4,669

-11,802

-8,557

0

0

0

Deferred cost of revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11,720

5,528

2,346

-162

-8,336

-14,673

-16,081

-15,996

-15,492

-13,111

-8,574

-1

10,065

16,972

17,438

13,379

7,829

1,261

-875

-73

0

0

0

Prepaid expenses and other assets

-2,630

63

-4,489

-6,342

-4,165

-3,579

-

-23,086

-39,631

-39,348

-35,210

13,400

37,923

37,125

31,042

7,350

-3,218

-339

-2,889

1,412

5,803

4,950

5,908

-686

-3,504

-1,477

-535

910

2,096

502

-47

-2,634

-1,232

684

148

0

0

0

Accounts payable

-13,619

-29,440

-6,355

12,235

16,118

4,596

-

1,120

-2,287

-6,388

11,759

10,135

13,826

12,971

4,236

2,464

-4,789

-1,644

-4,021

3,530

5,689

1,907

467

-4,814

-3,864

-2,786

6,359

1,637

-3,533

-460

2,554

4,494

9,315

-1,867

-7,818

0

0

0

Accrued liabilities

1,145

-1,836

-3,576

-4,934

1,982

2,791

-

-6,400

-25,735

-28,099

-20,184

10,807

28,863

33,552

34,913

11,248

8,120

4,636

-3,781

865

1,950

5,009

7,440

2,527

-2,080

-2,214

-4,217

5

2,103

-94

-869

-5,334

-5,923

-8,747

-386

0

0

0

Deferred revenue

3,753

2,401

773

617

-1,573

-1,426

-

-15,282

-28,050

-30,705

-14,370

13,325

30,935

35,794

16,398

5,273

3,513

1,034

-422

-8,099

-16,483

-19,018

-21,178

-24,497

-26,112

-18,064

-1,804

17,950

33,237

32,087

26,403

13,736

2,810

3,774

2,781

0

0

0

Other long-term liabilities

-2,656

-3,362

-2,528

-2,662

-1,615

-183

-

-181

473

85

246

-103

-449

-417

-412

-509

-435

-402

-363

-251

566

510

513

421

-437

-436

62

89

43

-10

-782

-767

-574

-635

-313

0

0

0

Net cash provided by (used in) operating activities

6,276

4,654

2,374

2,987

9,010

3,560

-

-28,927

-44,016

-45,141

-62,772

-9,466

-2,403

-4,304

24,419

1,111

6,718

11,825

-5,341

22,341

31,920

31,404

38,075

18,553

17,102

33,212

40,818

39,668

32,771

16,541

27,678

30,667

31,770

25,412

14,589

0

0

0

Investing activities:
Purchases of property and equipment

10,043

13,353

17,249

17,009

13,590

10,426

-

6,801

6,266

7,795

8,026

11,261

11,476

10,492

9,839

6,699

6,738

6,989

7,278

8,423

11,251

11,795

11,961

10,993

8,050

7,569

6,987

7,775

7,148

8,493

10,179

8,963

9,143

8,645

7,355

0

0

0

Purchases of marketable securities

-

-

-

-

-

-

-

-

-

-

8,732

25,210

25,210

25,210

16,478

13,252

34,731

42,998

60,002

65,092

46,397

84,702

67,698

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Maturities of marketable securities

-

-

-

-

-

-

-

-

-

-

31,441

43,071

45,246

42,646

38,400

40,850

55,783

67,515

71,945

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of product line

-

-

-

-

-

10,350

-

10,350

10,350

10,350

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Maturities of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

31,755

0

0

0

Acquisitions, net of cash acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

60,809

0

0

0

Net cash used in investing activities

-10,043

-13,353

-17,249

-17,009

-13,590

-76

-

10,149

17,009

27,781

19,734

11,651

13,611

6,944

12,083

20,899

14,314

17,528

4,665

-18,650

-25,601

-80,832

-75,444

-59,734

-54,622

-7,569

-6,987

-19,775

-19,148

-20,493

-22,179

-6,963

-293

184

-36,409

0

0

0

Financing activities:
Proceeds from exercise of stock options

1,251

442

631

659

666

384

-

112

84

57

62

32

32

16

17

27

62

88

638

1,864

2,119

2,211

1,668

505

598

726

747

0

0

0

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options and other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

276

722

804

0

0

0

Payments for repurchases of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12,809

28,862

36,609

39,986

27,177

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Taxes paid for awards vested under equity incentive plan

140

167

187

223

96

74

-

74

141

1,676

2,764

3,057

3,184

2,943

2,101

2,046

2,389

2,097

2,352

2,308

2,853

2,753

2,720

3,844

4,506

3,914

3,441

0

0

0

-

-

-

-

-

-

-

-

Payments related to financing arrangements

2,926

2,737

2,002

1,267

653

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from line of credit

143,300

143,300

266,452

358,851

424,677

557,915

-

507,497

459,332

334,506

171,268

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of line of credit

143,300

143,300

272,152

363,851

424,677

557,915

-

507,497

429,332

304,506

141,268

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments to originate the line of credit

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) financing activities

6,441

5,971

390

1,672

7,099

7,492

-

7,934

37,798

33,073

31,990

30,207

266

2,723

-9,243

-26,091

-34,146

-37,245

-24,141

-6,529

928

4,085

3,575

1,463

593

1,324

1,818

1,745

2,646

2,483

2,513

3,411

2,865

-5,716

-5,634

0

0

0

Effect of exchange rate changes on cash, cash equivalents and restricted cash

-552

-89

-362

-255

-452

-477

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Effect of exchange rate changes on cash, cash equivalents and restricted cash

-

-

-

-

-

-

-

-

-

-

-

28

-225

-410

-526

-349

-513

-361

-386

-367

-118

-208

-124

-7

91

143

103

64

25

-34

45

0

0

0

-

-

-

-

Net decrease in cash, cash equivalents and restricted cash

2,122

-2,817

-14,847

-12,605

2,067

10,499

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

0

0

4,953

-

-4,430

-13,627

-8,253

-25,203

-3,205

7,129

-45,551

-33,918

-39,725

-36,836

27,110

35,752

21,702

16,294

-1,503

8,057

27,173

34,425

20,015

-27,366

0

0

0

Non-cash investing activities:
Value of common stock issued in acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

117,258

0

0

0

Fair value of equity awards assumed in connection with acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,370

0

0

0